Cargando…
Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults
BACKGROUND: Prevention of infectious diseases is of high priority in the rapidly aging population. Unfortunately, vaccine responses in the elderly are frequently diminished. Timely vaccination of middle-aged adults might improve the immune responses to vaccines, although knowledge on pathogen-specif...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787056/ https://www.ncbi.nlm.nih.gov/pubmed/29410671 http://dx.doi.org/10.3389/fimmu.2018.00046 |
_version_ | 1783295853077725184 |
---|---|
author | van der Heiden, Marieke de Rond, Lia G. H. van Zelm, Menno C. Berbers, Guy A. M. Boots, Annemieke M. H. Buisman, Anne-Marie |
author_facet | van der Heiden, Marieke de Rond, Lia G. H. van Zelm, Menno C. Berbers, Guy A. M. Boots, Annemieke M. H. Buisman, Anne-Marie |
author_sort | van der Heiden, Marieke |
collection | PubMed |
description | BACKGROUND: Prevention of infectious diseases is of high priority in the rapidly aging population. Unfortunately, vaccine responses in the elderly are frequently diminished. Timely vaccination of middle-aged adults might improve the immune responses to vaccines, although knowledge on pathogen-specific immune responses and factors affecting these responses, in middle-aged adults is currently limited. We thus investigated the immune responses after vaccination with Zostavax consisting of live-attenuated varicella zoster virus (VZV). METHODS: Blood samples were taken pre-, 14 days, 28 days, and 1 year after a primary VZV vaccination (Zostavax) at middle age (N = 53, 50–65 years of age). VZV-specific IFNγ-producing cells were measured by ELISpot, activated T-cells by flow cytometry, antibody levels and cytokine responses by fluorescent bead-based multiplex immunoassays, and whole blood cellular kinetics by TruCOUNT analysis. RESULTS: Robust short-term enhancement of the VZV-specific IFNγ-producing cell numbers was observed post-vaccination in the middle-aged adults. Remarkably, long-term enhancement of VZV-specific IFNγ-producing cell numbers was induced only in participants with low numbers of VZV-specific pre-vaccination IFNγ-producing cells, who were significantly older. These participants also showed enhancement of VZV-specific activated CD4 T-cells, contrary to “exhausted” VZV-specific CD8 T-cells in participants with high numbers of VZV-specific pre-vaccination IFNγ-producing cells. Finally, a high CD4/CD8 T-cell ratio was associated with low numbers of pre-vaccination VZV-specific IFNγ-producing cells. CONCLUSION: These results suggest that adults in their early sixties, who showed a high CD4/CD8 T-cell ratio and low numbers of VZV-specific IFNγ-producing cells, benefit from VZV vaccination. This provides important knowledge on factors affecting VZV-specific immune responses in middle-aged adults as well as for strategies to strengthen immunity before reaching old age. |
format | Online Article Text |
id | pubmed-5787056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57870562018-02-06 Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults van der Heiden, Marieke de Rond, Lia G. H. van Zelm, Menno C. Berbers, Guy A. M. Boots, Annemieke M. H. Buisman, Anne-Marie Front Immunol Immunology BACKGROUND: Prevention of infectious diseases is of high priority in the rapidly aging population. Unfortunately, vaccine responses in the elderly are frequently diminished. Timely vaccination of middle-aged adults might improve the immune responses to vaccines, although knowledge on pathogen-specific immune responses and factors affecting these responses, in middle-aged adults is currently limited. We thus investigated the immune responses after vaccination with Zostavax consisting of live-attenuated varicella zoster virus (VZV). METHODS: Blood samples were taken pre-, 14 days, 28 days, and 1 year after a primary VZV vaccination (Zostavax) at middle age (N = 53, 50–65 years of age). VZV-specific IFNγ-producing cells were measured by ELISpot, activated T-cells by flow cytometry, antibody levels and cytokine responses by fluorescent bead-based multiplex immunoassays, and whole blood cellular kinetics by TruCOUNT analysis. RESULTS: Robust short-term enhancement of the VZV-specific IFNγ-producing cell numbers was observed post-vaccination in the middle-aged adults. Remarkably, long-term enhancement of VZV-specific IFNγ-producing cell numbers was induced only in participants with low numbers of VZV-specific pre-vaccination IFNγ-producing cells, who were significantly older. These participants also showed enhancement of VZV-specific activated CD4 T-cells, contrary to “exhausted” VZV-specific CD8 T-cells in participants with high numbers of VZV-specific pre-vaccination IFNγ-producing cells. Finally, a high CD4/CD8 T-cell ratio was associated with low numbers of pre-vaccination VZV-specific IFNγ-producing cells. CONCLUSION: These results suggest that adults in their early sixties, who showed a high CD4/CD8 T-cell ratio and low numbers of VZV-specific IFNγ-producing cells, benefit from VZV vaccination. This provides important knowledge on factors affecting VZV-specific immune responses in middle-aged adults as well as for strategies to strengthen immunity before reaching old age. Frontiers Media S.A. 2018-01-23 /pmc/articles/PMC5787056/ /pubmed/29410671 http://dx.doi.org/10.3389/fimmu.2018.00046 Text en Copyright © 2018 van der Heiden, de Rond, van Zelm, Berbers, Boots and Buisman. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology van der Heiden, Marieke de Rond, Lia G. H. van Zelm, Menno C. Berbers, Guy A. M. Boots, Annemieke M. H. Buisman, Anne-Marie Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults |
title | Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults |
title_full | Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults |
title_fullStr | Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults |
title_full_unstemmed | Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults |
title_short | Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults |
title_sort | age-dependent pre-vaccination immunity affects the immunogenicity of varicella zoster vaccination in middle-aged adults |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787056/ https://www.ncbi.nlm.nih.gov/pubmed/29410671 http://dx.doi.org/10.3389/fimmu.2018.00046 |
work_keys_str_mv | AT vanderheidenmarieke agedependentprevaccinationimmunityaffectstheimmunogenicityofvaricellazostervaccinationinmiddleagedadults AT derondliagh agedependentprevaccinationimmunityaffectstheimmunogenicityofvaricellazostervaccinationinmiddleagedadults AT vanzelmmennoc agedependentprevaccinationimmunityaffectstheimmunogenicityofvaricellazostervaccinationinmiddleagedadults AT berbersguyam agedependentprevaccinationimmunityaffectstheimmunogenicityofvaricellazostervaccinationinmiddleagedadults AT bootsannemiekemh agedependentprevaccinationimmunityaffectstheimmunogenicityofvaricellazostervaccinationinmiddleagedadults AT buismanannemarie agedependentprevaccinationimmunityaffectstheimmunogenicityofvaricellazostervaccinationinmiddleagedadults |